Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
1,719
Value
$289.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NBIX by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,719$289.7K<0.1%−57−3.2%ReducedHolders
Q1 20261,776$234.0K<0.1%+195+12.3%AddedHolders
Q4 20251,581$224.2K<0.1%−51−3.1%ReducedHolders
Q3 20251,632$229.1K<0.1%+41+2.6%AddedHolders
Q2 20251,591$200.0K<0.1%+212+15.4%AddedHolders
Q1 20251,379$152.5K<0.1%−632−31.4%ReducedHolders
Q4 20242,011$274.5K<0.1%+172+9.4%AddedHolders
Q3 20241,839$211.9K<0.1%+140+8.2%AddedHolders
Q2 20241,699$233.9K<0.1%+12+0.7%AddedHolders
Q1 20241,687$232.7K<0.1%+151+9.8%AddedHolders
Q4 20231,536$202.4K<0.1%−308−16.7%ReducedHolders
Q3 20231,844$207.4K<0.1%+713+63.0%AddedHolders
Q2 20231,131$106.7K<0.1%+88+8.4%AddedHolders
Q1 20231,043$105.6K<0.1%+79+8.2%AddedHolders
Q4 2022964$115.1K<0.1%+123+14.6%AddedHolders
Q3 2022841$89.0K<0.1%+256+43.8%AddedHolders
Q2 2022585$57.0K<0.1%−54−8.5%ReducedHolders
Q1 2022639$59.0K<0.1%+175+37.7%AddedHolders
Q4 2021464$40.0K<0.1%+1+0.2%AddedHolders
Q3 2021463$44.0K<0.1%+261+129.2%AddedHolders
Q2 2021202$20.0K<0.1%+27+15.4%AddedHolders
Q1 2021175$17.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.